PGGT1B and melanoma: We previously demonstrated [1] that murine B16F10 melanoma cells present a modified phenotype following in vitro treatment by mIFN-γ in association with GGTI-298, characterized by an up regulation of MHC-I and the GGTI-induced expression of CD80 and CD86 costimulatory molecules.